Fundz

Laborie Medical Technologies Invests In Medical Technology Start-Up Bright Uro

PRIVATENov 30, 2023

Round Type

Funding Round

IrvineSoftwareMobileHealth Care

Investors

Laborie Medical Technologies Corp.

Description

Leading diagnostic and therapeutic medical technology company Laborie Medical Technologies Corp. (Laborie) announced a strategic equity investment in Bright Uro, an early-stage medical technology company headquartered in Irvine, CA.

Quick answer

Bright Uro raised an undisclosed amount in a Funding Round round, dated November 30, 2023. Investors: Laborie Medical Technologies Corp. Bright Uro is based in Irvine, California, United States.

How much did Bright Uro raise?
Bright Uro raised an undisclosed amount in a Funding Round round on November 30, 2023.
Who invested in Bright Uro?
Laborie Medical Technologies Corp. is named as investors in this round.
What does Bright Uro do?
Bright Uro is an early-stage medical technology company.
Where is Bright Uro based and how big is it?
Bright Uro is based in Irvine, California, United States. Fundz records about 26 employees.
Who are the decision-makers at Bright Uro?
Fundz holds 1 contact at Bright Uro. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Mobile and Software around the same time

Companies in the same sectors as Bright Uro that raised within 45 days of this round, from Fundz verified event records.

  • Streamex Corp. raised $1.5M (Seed) on January 12, 2024.
  • Nabla raised $24M (Series B) on January 5, 2024.
  • BrainCheck, Inc. raised $15M on December 21, 2023.
  • Atavistik Bio raised $40M (Funding Round) on December 19, 2023.
  • Laza Medical raised $36M (Series A) on December 12, 2023.
  • Weave raised $11M on December 8, 2023.

Who to call at Bright Uro, and when

A new round usually means Bright Uro is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bright Uro raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bright Uro, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bright Uro. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bright Uro

Location

Irvine, California, United States

About

Bright Uro is an early-stage medical technology company. It is building the next generation of diagnostic devices for Urology. Utilizing advanced hardware, software, and data science can unlock new data streams and offer actionable insight for clinicians.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bright Uro raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Bright Uro's next move

See what Strategic adds

Bright Uro raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.